Texas Oncology Cancer Center is a clinical research site located in Austin, Texas, United States 78731.
Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
Texas Oncology Cancer Center has participated in 28 clinical trials with 3 currently active.
Therapeutic areas: Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL), Metastatic Breast Cancer, Gastric Cancer Adenocarcinoma Metastatic.
Sponsors: Millennium Pharmaceuticals, Inc., Eli Lilly and Company, US Oncology Research.
Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Texas Oncology Cancer Center has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Oncology Cancer Center has 28 clinical trials on record, with 3 currently active. Their work covers Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL), Metastatic Breast Cancer, Gastric Cancer Adenocarcinoma Metastatic.
Yes — Texas Oncology Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.